Trade-Ideas LLC identified

Heartware International

(

HTWR

) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Heartware International as such a stock due to the following factors:

  • HTWR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $19.6 million.
  • HTWR traded 47,601 shares today in the pre-market hours as of 8:46 AM, representing 17.3% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HTWR with the Ticky from Trade-Ideas. See the FREE profile for HTWR NOW at Trade-Ideas

More details on HTWR:

HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, Germany, and internationally. Currently there are 7 analysts that rate Heartware International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Heartware International has been 269,000 shares per day over the past 30 days. Heartware International has a market cap of $1.5 billion and is part of the health care sector and health services industry. The stock has a beta of 0.54 and a short float of 27.6% with 10.02 days to cover. Shares are up 16.6% year-to-date as of the close of trading on Monday.

TheStreet Recommends

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Heartware International as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share.

Highlights from the ratings report include:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 427.5% when compared to the same quarter one year ago, falling from $8.36 million to -$27.39 million.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, HEARTWARE INTERNATIONAL INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • HEARTWARE INTERNATIONAL INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, HEARTWARE INTERNATIONAL INC continued to lose money by earning -$1.15 versus -$3.68 in the prior year. For the next year, the market is expecting a contraction of 73.0% in earnings (-$1.99 versus -$1.15).
  • The gross profit margin for HEARTWARE INTERNATIONAL INC is rather high; currently it is at 68.67%. Regardless of HTWR's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, HTWR's net profit margin of -37.23% significantly underperformed when compared to the industry average.
  • Net operating cash flow has slightly increased to $5.29 million or 5.23% when compared to the same quarter last year. Despite an increase in cash flow, HEARTWARE INTERNATIONAL INC's cash flow growth rate is still lower than the industry average growth rate of 21.53%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.